These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37446344)

  • 41. Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy.
    Sayed N; Liu C; Ameen M; Himmati F; Zhang JZ; Khanamiri S; Moonen JR; Wnorowski A; Cheng L; Rhee JW; Gaddam S; Wang KC; Sallam K; Boyd JH; Woo YJ; Rabinovitch M; Wu JC
    Sci Transl Med; 2020 Jul; 12(554):. PubMed ID: 32727917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.
    Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G
    Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-syndromic cardiac progeria in a patient with the rare pathogenic p.Asp300Asn variant in the LMNA gene.
    Marian AJ
    BMC Med Genet; 2017 Oct; 18(1):116. PubMed ID: 29047356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.
    Hasselberg NE; Haland TF; Saberniak J; Brekke PH; Berge KE; Leren TP; Edvardsen T; Haugaa KH
    Eur Heart J; 2018 Mar; 39(10):853-860. PubMed ID: 29095976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
    Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
    J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy.
    Sysi-Aho M; Koikkalainen J; Seppänen-Laakso T; Kaartinen M; Kuusisto J; Peuhkurinen K; Kärkkäinen S; Antila M; Lauerma K; Reissell E; Jurkko R; Lötjönen J; Heliö T; Orešič M
    PLoS One; 2011 Jan; 6(1):e15744. PubMed ID: 21283746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects.
    Gerbino A; Bottillo I; Milano S; Lipari M; Zio R; Morlino S; Mola MG; Procino G; Re F; Zachara E; Grammatico P; Svelto M; Carmosino M
    Cell Physiol Biochem; 2017; 44(4):1559-1577. PubMed ID: 29197877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics.
    Ho CY; Jaalouk DE; Vartiainen MK; Lammerding J
    Nature; 2013 May; 497(7450):507-11. PubMed ID: 23644458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lamin and the heart.
    Captur G; Arbustini E; Bonne G; Syrris P; Mills K; Wahbi K; Mohiddin SA; McKenna WJ; Pettit S; Ho CY; Muchir A; Gissen P; Elliott PM; Moon JC
    Heart; 2018 Mar; 104(6):468-479. PubMed ID: 29175975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy.
    Lee YK; Jiang Y; Ran XR; Lau YM; Ng KM; Lai WH; Siu CW; Tse HF
    Stem Cell Res Ther; 2016 Sep; 7(1):139. PubMed ID: 27649756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
    Siu CW; Lee YK; Ho JC; Lai WH; Chan YC; Ng KM; Wong LY; Au KW; Lau YM; Zhang J; Lay KW; Colman A; Tse HF
    Aging (Albany NY); 2012 Nov; 4(11):803-822. PubMed ID: 23362510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting unfolded protein response reverts ER stress and ER Ca
    Pietrafesa G; De Zio R; Scorza SI; Armentano MF; Pepe M; Forleo C; Procino G; Gerbino A; Svelto M; Carmosino M
    J Transl Med; 2023 May; 21(1):340. PubMed ID: 37217929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations.
    Le Dour C; Chatzifrangkeskou M; Macquart C; Magiera MM; Peccate C; Jouve C; Virtanen L; Heliö T; Aalto-Setälä K; Crasto S; Cadot B; Cardoso D; Mougenot N; Adesse D; Di Pasquale E; Hulot JS; Taimen P; Janke C; Muchir A
    Nat Commun; 2022 Dec; 13(1):7886. PubMed ID: 36550158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
    Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
    Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.
    Taylor MR; Fain PR; Sinagra G; Robinson ML; Robertson AD; Carniel E; Di Lenarda A; Bohlmeyer TJ; Ferguson DA; Brodsky GL; Boucek MM; Lascor J; Moss AC; Li WL; Stetler GL; Muntoni F; Bristow MR; Mestroni L;
    J Am Coll Cardiol; 2003 Mar; 41(5):771-80. PubMed ID: 12628721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attenuated hypertrophic response to pressure overload in a lamin A/C haploinsufficiency mouse.
    Cupesi M; Yoshioka J; Gannon J; Kudinova A; Stewart CL; Lammerding J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1290-7. PubMed ID: 19913544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene.
    Wu W; Muchir A; Shan J; Bonne G; Worman HJ
    Circulation; 2011 Jan; 123(1):53-61. PubMed ID: 21173351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice.
    En A; Bogireddi H; Thomas B; Stutzman AV; Ikegami S; LaForest B; Almakki O; Pytel P; Moskowitz IP; Ikegami K
    Cell Rep; 2024 Jun; 43(6):114284. PubMed ID: 38814785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
    Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
    J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.